_________
false
אבוגן בע"מ
2
381
EVOGENE LTD
Corporation no:
512838723
10571
Israel Securities Authority
Tel Aviv Stock Exchange
C003
(
Public
)
Reported via MAGNA:
03/03/2022
www.isa.gov.il
www.tase.co.il
Reference:
2022-02-026017
Time of broadcast:
13:37
13:37
Other Report or Announcement
Regulation 5 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000
The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on
PR - Evogene to Attend ROTH Investor Conference - March 13-15, 2022
Evogene_-_Roth_Conference_2022_isa.pdf
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Stock Exchange/Market:
-1
Date of revision of form structure:
22/02/2022
Address:
Gad Feinstein St
13, P.O.B 2100
,
Rehovot
76121
,
Tel:
08-9311900
,
Fax:
08-9466724
E-mail address:
ofer.haviv@evogene.com
Company site:
www.evogene.com
Previous names of reporting entity:
Name of the Signatory:
Masliah Sassi
Position of Signatory in the reporting corporation:
Director of Legal Affairs & Company Secretary
Name of Employer Company:
Address:
Gad Feinstein
13
,
Rehovot
7612001
Telephone:
08-9311901
Facsimile:
08-9466724
E-mail:
sassi.masliah@evogene.com
1